Expression of p53-family members and associated target molecules in breast cancer cell lines in response to vincristine treatment

Biochemical Pharmacology

Volumn 63, Issue 9, 2002, Pages 1609-1617

  Vayssade, Muriel ^a   Faridoni Laurens, Laetitia ^a   Bénard, Jean ^a   Ahomadegbe, Jean Charles ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

p53; p63; p73; Vincristine

Indexed keywords

CISPLATIN; CISPLATINE; DOXORUBICIN; PROTEIN P21; PROTEIN P53; PROTEIN P63; PROTEIN P73; VINCRISTINE; VINCRISTINE SULFATE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; VINCRISTINE;

EID: 0036569629     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)00917-6     Document Type: Article

References (46)

1. WAF1, a potential mediator of p53 tumor suppression
2. 14-3-3σ is a p53-regulated inhibitor of G2/M progression
3. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
4. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
5. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
6. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death
7. Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugs
8. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase
9. Molecular effects of paclitaxel: Myths and reality (a critical review)
10. P53-independent apoptosis induced by paclitaxel through an indirect mechanism
11. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
12. A new human p53 homologue
13. Cloning and functional analysis of human p51, which structurally and functionally resembles p53
14. P63, a p53 homolog at 3q27-29, encodes multiples products with transactivating, death-inducing and dominant-negative activities
15. P73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours
16. P73 is a human p53-related protein that can induce apoptosis
17. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters
18. The potential tumor suppressor p73 differentially regulates cellular p53 target genes
19. P73 function is inhibited by tumor-derived p53 mutants in mammalian cells
20. The transcriptional activities of p53 and its homologue p51/p63: Similarities and differences
21. Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins
22. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells
23. Comparative analysis of p73 and p53 regulation and effector functions
24. P73 competes with p53 and attenuates its response in a human ovarian cancer cell line
25. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions
26. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
27. Interaction of c-Abl and p73α and their collaboration to induce apoptosis
28. P73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
29. P51A (TAp63γ), a p53 homolog, accumulates in response to DNA damage for cell regulation
30. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis
31. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; Absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions
32. P73 expression in basal layers of head and neck squamous epithelium: A role in differentiation and carcinogenesis in concert with p53 and p63?
33. Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers
34. CIP1/WAF1 expression in human breast epithelial cells
35. WAF1/CIP1 response to genotoxic agents in wild-type TP53 expressing breast primary tumours
36. Down-regulation of bcl-2 by p53 in breast cancer cells
37. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
38. New p73 variants with altered C-terminal structures have varied transcriptional activities
39. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines
40. High frequency of hypermethylation at the 14-3-3σ locus leads to gene silencing in breast cancer
41. Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway
42. P53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
43. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53
44. Analysis of p73 in human borderline and invasive ovarian tumor
45. P73 is overexpressed in vulval cancer principally as the Delta2isoform
46. Acquired expression of transcriptionally active p73 in hepatocellular carcinomas cells